G
Guardant Health, Inc. (GH)
84.61
0.00 (0.00%)

84.61
0.00 (0.00%)
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.84 | 2.46 | 10 | |
| Quick ratio | 4.56 | 2.06 | 10 | |
| Debt to Equity | N/A | -0.13 | 1.0 | |
| Debt to Assets | 0.85 | 1.87 | 2.0 | |
| Interest coverage | -101.93 | 4.31 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 450M | 564M | 739M | 982M | 982M |
| Gross Profit | 292M | 337M | 449M | 633M | 633M |
| Operating Income | -535M | -563M | -444M | -436M | -437M |
| Net Income | -655M | -479M | -436M | -416M | -416M |
| EBITDA | -499M | -520M | -401M | -397M | -397M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 37.51 | -5.06 | 5.5 |
| Next quarter | 32.01 | 5.24 | 7.5 |
| Current year | 29.53 | 11.06 | 8.5 |
| Next year | 28.33 | 33.4 | 10 |
| Weighted average score | 7.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 6.06 | -38.57 | -35.13 | 8.37 | 3.3 |
| Y/Y | 39.37 | -15.74 | -11.1 | 49.71 | 5.5 |
| 3y average | 29.79 | 13.45 | 18.93 | 15.45 | 9.0 |
| 5y average | 28 | -16.16 | -11.45 | -18.51 | 3.3 |
| Weighted average score | 5.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Medium | 6.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | Medium | 6.0 |
| Network effect | Narrow | 4.0 |
| Economies of scale | Medium | 6.0 |
| Weighted average score | 5.8 | |
Total debt $1.7B significantly exceeds cash reserves ($378.2M), raising financial stability concerns
Total current assets $1.5B exceed Total current liabilities $302.7M, highlighting excellent liquidity
Debt-to-equity ratio (-17.2) is well below the industry average (-0.1), showcasing prudent financial management
Interest coverage ratio (-101.9x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$41.9M limits the company's ability to reinvest or pay down debt